INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 436m ago
HOUSE PTR36m ago
SEC 13F36m ago
ROBINHOOD CHAIN35m ago
SB
Corporate insider

Stone Benjamin

Chief Business OfficerCIK 0002128786

EDGAR filingsOpen in network
Disclosed transactions4
Buys / sells0 / 0
Max Insider Score21
Connections with evidence1

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
SB
Stone BenjaminChief Business Officer
TRAXFirst Tracks Biotherapeutics, Inc.
Grant or award
A—
42.5K sh
Nov 1, 2026Nov 3, 2026
traded Nov 1, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    First Tracks Biotherapeutics, Inc.Chief Business Officer · May 14, 2026
21
SB
Stone BenjaminChief Business Officer
TRAXFirst Tracks Biotherapeutics, Inc.
Grant or award
A
—
60.5K sh
Aug 15, 2026
Aug 18, 2026
traded Aug 15, 2026
+3d
SEC FORM 4

Evidence

9
SB
Stone BenjaminChief Business Officer
TRAXFirst Tracks Biotherapeutics, Inc.
Grant or award
A—
26.7K sh
May 12, 2026May 14, 2026
traded May 12, 2026
+2dSEC FORM 4

Evidence

9
SB
Stone BenjaminChief Business Officer
TRAXFirst Tracks Biotherapeutics, Inc.
Grant or award
A—
72.3K sh
May 12, 2026May 14, 2026
traded May 12, 2026
+2dSEC FORM 4

Evidence